The NHS Scotland approved funding PrEP drugs for people at risk of contracting HIV.
Successful experiments conducted at the University of Liverpool reveals that nanotechnology can help improve drug therapies for HIV patients.
An experiment combining two AIDS treatments shows impressive capabilities to reduce the viral load of HIV-infected cells.
Canada is pioneering in providing affordable universal healthcare most especially to AIDS victims. This move is believed to be one of the best ways to bring an end to AIDS and other HIV diseases.
Taking HIV drugs used to slow down the infection's progression to Acquired Immunodeficiency Syndrome (AIDS) may increase the risk of gay men contracting syphilis, another sexually transmitted infection.
Now they are known to be "functionally" cured, meaning they do not need to take Art even though they may still harbor the HIV virus. The same is true with a perinatally infected baby who stopped ART at 5, continues to be in remission now at 18 years old. However, the Mississippi baby is not so fortunate, suffering a relapse after ART for the first 18 months and just 27 months of full remission.